Ionpath

About:

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.

Top Investors: Bossanova Investimentos, Thermo Fisher Scientific, Bruker, Samsara BioCapital, Genoa Ventures

Description:

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

Total Funding Amount:

$18M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2014-01-01

Contact Email:

partnerships(AT)ionpath.com

Founders:

Harris Fienberg, Mike Angelo

Number of Employees:

11-50

Last Funding Date:

2022-05-11

IPO Status:

Private

Industries: